Bristol-Myers Squibb

J&j Files Application For Darzalex Label Expansion In Europe

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY): Free Stock Analysis Report Bristol-Myers Squibb Company...

Read More →

Why Bristol-myers Squibb (bmy) Is A Great Dividend Stock Right Now

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report To read this article...
Related topics: Dividend

Read More →

Bristol-myers' Celgene Buyout Still Uncertain Amid Opposition

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Roche Holding AG...

Read More →

Merck's Keytruda Picks Up Pace In Thriving Anti-pd-l1 Market

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report AstraZeneca PLC (AZN):...
Related topics: Merck & Co, Astrazeneca

Read More →

Starboard Vs. Bristol-myers Squibb: Who'll Win This Brewing Battle?

It doesn't look as if Bristol-Myers Squibb (NYSE: BMY) sought approval from its largest shareholders before offering Celgene (NASDAQ: CELG) a whopping $90 billion earlier this year.Starboard Value owns a sliver of Bristol-Myers Squibb's outstanding...
Related topics: US Equity Markets, Nasdaq

Read More →

Bristol-myers & Pfizer Release Phase Iv Data On Eliquis

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE):...
Related topics: Pfizer

Read More →

Celgene (celg) Submits Application For Ms Drug In Europe

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Biogen Inc. (BIIB):...

Read More →

Is Bristol-myers (bmy) A Solid Pick For Value Investors?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report To read this article...

Read More →

Celldex (cldx) Q4 Loss Narrower Than Expected, Sales Beat

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: Celldex

Read More →

Nektar (nktr) Q4 Earnings Beat, Nktr-181 Review Extended

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Pfizer Inc. (PFE):...
Related topics: Pfizer

Read More →

Merck To Buy Immunotherapy Developer Immune Design For $300m

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: Merck & Co

Read More →

Bausch (bhc) Q4 Earnings Beat Estimates, Revenues Down Y/y

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: GlaxoSmithKline (business)

Read More →

2 Healthcare Stocks Ripe For A Takeover

The healthcare sector has a well-earned reputation for ultra-pricey acquisitions. In 2017, for example, Gilead Sciences paid nearly $12 billion for Kite Pharma and its commercially unproven cell therapy platform. Kicking off this year,...

Read More →

Strength Seen In Astrazeneca (azn): Stock Soars 9.3%

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report AstraZeneca PLC (AZN):...
Related topics: Astrazeneca

Read More →

Johnson & Johnson (jnj) To Acquire Auris Health For $3.4b

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ): Free Stock Analysis Report Bristol-Myers Squibb Company...

Read More →

Aduro Initiates Dosing In Phase I Melanoma Study On Adu-s100

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report Bristol-Myers Squibb Company (BMY):...
Related topics: Novartis

Read More →

The Zacks Analyst Blog Highlights: Bristol-myers, Conocophillips, Qualcomm, General Motors And...

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report QUALCOMM Incorporated...
Related topics: ConocoPhillips, Qualcomm (business), General Motors

Read More →

Abbvie Buys Rights To Novel Immunotherapy For Multiple Myeloma

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report AbbVie Inc. (ABBV):...

Read More →

3 Reasons Growth Investors Will Love Bristol-myers (bmy)

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Get Free Report To read this article on Zacks.com...

Read More →

Alnylam's (alny) Q4 Earnings And Revenues Beat Estimates

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Get Free Report Sanofi (SNY): Free Stock Analysis...
Related topics: Sanofi

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.